Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Commentary

Erythropoietin in the critically ill – is it more than just blood?

Howard L Corwin

Author Affiliations

Professor of Medicine and Anesthesiology, Dartmouth Medical School, Section Chief, Critical Care Medicine, Medical Director, Intensive Care Unit, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA

Critical Care 2004, 8:325-326  doi:10.1186/cc2949


See related review article, http://ccforum.com/content/8/5/337

Published: 6 September 2004

Abstract

Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.

Keywords:
apoptosis; erythropoietin; sepsis